Molecular Testing for Thalassemia: Mutation DetectionAccording to Referral Reasons and Demographic Data

Conclusion: Our results highlight the importance of positive family history and evaluation of hematologic parameters andconsanguinity in mutation detection for thalassemias.

📌 3 Maddede Bu Makale

🎯

Amaç & Hipotez:Objective: Thalassemia is the most common inherited blood disorder worldwide and an important public health problemin Mediterranean countries such as Turkey.

📊

Temel Bulgular & Veri:In this study, we aimed to define mutation detection rates according to referralreasons based on molecular testing results.

💡

Sonuç & Katkı:Conclusion: Our results highlight the importance of positive family history and evaluation of hematologic parameters andconsanguinity in mutation detection for thalassemias.

🔬Tür:Araştırma Makalesi

📍Kapsam:2017 Verileri

⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Thalassemia is the most common inherited blood disorder worldwide and an important public health problemin Mediterranean countries such as Turkey. In this study, we aimed to define mutation detection rates according to referralreasons based on molecular testing results. Materials and Methods: The data of 315 patients tested for thalassemia using the reverse dot-blot method between 2007and 2017 at the Department of Medical Genetics, Ankara University School of Medicine, were analyzed. Results: The most frequent mutations were 3.7-kb deletion and IVS1.110 [G>A] for alpha (α)- and beta (β)-thalassemia, re spectively. Statistical correlation was found between the samples identified after clinical indication and the mutation detectionrate in α-thalassemia (Pearson chi-square two-sided p=0.006). Moroever, a statistically significant correlation was detectedbetween the β-thalassemia mutation rate and positive family history (continuity-to-correction two-sided p=0.002). Conclusion: Our results highlight the importance of positive family history and evaluation of hematologic parameters andconsanguinity in mutation detection for thalassemias.

🔖

Bu Makaleye Atıf Yap

VİCDAN, A., ALTINER, Ş., TÜKÜN, A., TUNCALI, T., KARABULUT, H. G., KUTLAY, N., EKİNCİ, S., RUHİ, H. I. (2022). Molecular Testing for Thalassemia: Mutation DetectionAccording to Referral Reasons and Demographic Data. Erciyes Medical Journal, Cilt: 43 - Sayı: 5, 449–451. https://ajindex.com/articles/502213

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

Angastiniotis M, Lobitz S. Thalassemias: An overview. Int J Neonatal Screen 2019; 5(1):16
Sabath DE. Molecular diagnosis of thalassemias and hemoglobinopathies: An ACLPS critical review. Am J Clin Pathol 2017; 148(1): 6–15
Mettananda S, Higgs DR. Molecular basis and genetic modifiers of thalassemia. Hematol Oncol Clin North Am 2018; 32(2): 177–91
Keser İ. Hemoglobinopathies in Turkey and the World. Turkiye Klinikleri J Med Genet-Special Topics 2017; 2(1): 1–6
Aydınok Y, Oymak Y, Atabay B, Aydoğan G, Yeşilipek A, Ünal S, et al. A National Registry of Thalassemia in Turkey: Demographic and disease characteristics of patients, achievements, and challenges in prevention. Turk J Haematol 2018; 35(1): 12–8
Çürük MA, Kılınç Y. Genetic of Alpha Thalassemia. Turkiye Klinikleri J Med Genet-Special Topics 2017; 2(1): 21–6
Shang X, Xu X. Update in the genetics of thalassemia: What clinicians need to know. Best Pract Res Clin Obstet Gynaecol 2017; 39: 3–15
Abedini SS, Forouzesh Pour F, Karimi K, Ghaderi Z, Farashi S, Tavakoli Koudehi A, et al. Frequency of α-Globin gene triplications and coinheritance with β-Globin gene mutations in the Iranian population. Hemoglobin 2018; 42(4): 252–6